From Day 1 of Canada House, the focus has been on superior service, leading to superior results. To fully grasp this service-focused model requires delving into the history of this company, the foundation it was built on and understanding the value of the vertically integrated vision in a patient-centric focus displayed below. Today, CHV is a publicly listed Company with three divisions; Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp.
What gives Canada House a competitive advantage?
- The best standard of care for medicinal cannabis patients (MFT)
- A data analytics division with an enormous database and unique expertise (Knalysis), feeding and collecting data from its sister divisions; Marijuana for Trauma and Abba Medix.
- An in-house cultivation division providing cannabis crafted to MFT’s clients’ needs (Abba Medix). This allows Canada House to bring the same high standards to its (soon-to-be-produced) cannabis products as it already does with its cannabis clinics and its Knalysis division.